Saadi et al. [19] evaluated the expression levels of IL18 in AML patients according to their response to treatment and showed that expression levels of IL18 were increased in AML patients who did not respond to therapy compared to those patients who respond to therapy. Here, IL18 is linked to acute myeloid leukemia.